Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Vetoquinol SA

VETO.PA ✓ COMPLIANT ☆ Track — members

Euronext Paris · Healthcare · Pharmaceuticals ·

France Small Cap Analyst: BUY

Last Close

$82.02

▼ -0.56%

Market Cap $971.06M · Vol 5.03K

Key Metrics

P/E Ratio

14.34

FWD: 13.61

Market Cap

$971.06M

Small Cap

Div Yield

1.31%

Annual dividend

EPS Growth

+0.75%

YoY

RSI (14)

36.07

Momentum

Beta

0.68

vs Market

52W High

$105.86

24.46% below

52W Low

$77.74

5.27% above

Volume

5.03K

Avg 10.05K

P/B

1.64

Price-to-book

ROE

N/A

Return on equity

Free Float

31.51%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Vetoquinol SA (VETO.PA) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does VETO.PA pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-2.34%

-1.39%

-1.94%

-22.09%

YTD

-15.09%

-5.21%

-19.46%

-47.79%

Financials & Valuation

TTM · Annual

Total Revenue	$617.42M
Net Income	$67.34M
Revenue Growth (YoY)	-2.44%
Gross Margin	58.59%
Operating Margin	14.04%
Net Profit Margin	10.91%
ROE	N/A
ROA · ROIC	10.65% · 9.69%

P/E Ratio	14.34
Forward P/E (FY1)	13.61
PEG Ratio	-21.21
P/S	1.85
P/B	1.64
P/FCF	17.55
EPS Growth	+0.75%
Outstanding Shares	11.88M

Technical Indicators

50-Day SMA	$82.57
200-Day SMA	$89.07
RSI (14)	36.07
Beta	0.68
52-Week High	$105.86
52-Week Low	$77.74

Volume Today	5.03K
Avg Daily Volume (30D)	10.05K
Relative Volume	0.50x
Volatility (10D)	13.90
Volatility (30D)	16.84
Free Float	31.51%

Analyst Consensus

BUY

Current Price $82.02

Mean Target $98.48

52W Low$77.74 52W High$105.86

Current

Target

$77.74 $105.86

Current Analyst target

+20.06% upside potential · 5 analysts

Identifiers

ExchangeEuronext Paris

FIGIBBG001SF2VM8

ISINFR0004186856

CountryFrance

Sub-IndustryVeterinary Drugs

Earnings DateSep 11, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

ZTS Zoetis Inc -2.70% ELAN Elanco Animal Health Inc +5.15% 600299.SS Bluestar Adisseo Co -0.48% VIRP.PA Virbac SA +0.30% 600201.SS Jinyu Bio-Technology Co Ltd -0.81%

Company Profile

Vetoquinol SA is a France-based company that specializes in the research, development, manufacture, marketing and sale of veterinary drugs and products. The Company’s product portfolio is divided between livestock, such as cattle and pigs, and companion animals, including dogs and cats. Vetoquinol SA’s offering includes anti-infectives, such as Marbocyl; anti- pain inflammatories, which comprise Tolfedine, intended for dogs and cats, and Tolfine for livestock, and cardiovascular and nephrology treatment, such as Prilium, an oral daily administration formula for dogs, among others. The Company markets over 700 products, in such countries as France, Austria, Canada, Italy, Poland, Spain and the Netherlands, among others. It trades its products throughout Europe, North America, Africa, the Middle East and Pacific Asia. In April 2014, it acquired Bioniche's animal health business.